The actor is raising awareness of clinical trials for cancer in partnership with “GMA” sponsor Eli Lilly & Co.

Eli Lilly and Company (NYSE:LLY) is one of the 13 best blue-chip stocks to buy, according to analysts. On June 30, RBC ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

While Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for ...

Since the city's establishment in the 1820s, Indianapolis has been a magnet for immigrants seeking opportunity and refuge.

Procedure was performed on 54-yr-old patient from Jharkhand suffering from advanced osteoarthritis and severe knee ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...

Exclusive Global Rights: Neurizon is granted exclusive global rights to Elanco's data package and related intellectual ...

Elanco (ELAN) stock in focus as Australia's Neurizon Therapeutics (PAAFF) enters into a licensing deal with the company for ...

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

Wall Street analysts remain bullish on Eli Lilly, boasting an Average Brokerage Recommendation (ABR) of 1.46, largely between ...